Bioscience Valuation offers the following services:
Financial evaluation and risk analysis of R&D projects, portfolios, marketed products, technology platforms and companies
- development of detailed financial models providing project, portfolio, product, platform technology or company value
- analyzing R&D-related technical risks and increasing the probability of discovery and development success
- generation of sales forecasts and development of market penetration models (together with
Bioscience Market Research)
- assessing commercial risks and increasing the probability of commercial success (together with
Bioscience Market Research)
- investigation of R&D strategies to minimize risk and to enhance project value
- strategy development for value-driven life cycle management
see Approach: Project valuation and value-driven project management
back to top
Portfolio evaluation and optimization
- quantitative and qualitative analysis to support project prioritization and selection
- improvement of resource allocation in order to create the most efficient portfolio
- calculation and analysis of expected portfolio cash flows
- gap analysis and design of strategies to increase portfolio value
- optimization of the R&D and product portfolio with respect to the clients strategic objectives and risk preference
- support for the strategic planning process
see Approach: Portfolio evaluation and optimization
back to top
Implementation of value-driven project and portfolio management
Company valuation and fund raising
- determination of company value in order to prepare for a financing round
- identifying and approaching potential investors
- organization of road shows and support in preparing the company presentation
- defending the valuation vis-à-vis potential investors
- negotiation of deal terms
see Approach: Company valuation and fund raising
back to top
Determination of fair and value-maximizing partnering and licensing conditions
- assessment of the financial value of a licensing candidate, technology platform, or a firms contribution to a collaboration
- fair risk-sharing between licensing partners towards a win-win scenario
- finding the right balance between upfront payments, milestone payments, equity transfers and royalties
- evaluating and integrating options in the partnering agreement
- support during licensing negotiations
see Approach: Licensing and partnering
back to top
Evaluation of research and technology investments as real options
- determination of the option value of strategic research and technology investments
- identifying and assessing a projects strategic opportunities
- evaluation of operating and growth options
see Approach: Real options
back to top
|